Henry Schein, Inc. $HSIC Shares Purchased by CX Institutional

CX Institutional boosted its holdings in shares of Henry Schein, Inc. (NASDAQ:HSIC) by 107.3% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 651 shares of the company’s stock after acquiring an additional 337 shares during the period. CX Institutional’s holdings in Henry Schein were worth $48,000 at the end of the most recent reporting period.

A number of other institutional investors have also bought and sold shares of HSIC. Two Sigma Investments LP boosted its holdings in shares of Henry Schein by 216.6% during the 4th quarter. Two Sigma Investments LP now owns 30,709 shares of the company’s stock worth $2,125,000 after purchasing an additional 21,009 shares during the last quarter. Toronto Dominion Bank lifted its position in Henry Schein by 6.7% during the fourth quarter. Toronto Dominion Bank now owns 66,997 shares of the company’s stock worth $4,636,000 after buying an additional 4,218 shares in the last quarter. Forum Financial Management LP purchased a new stake in Henry Schein in the 4th quarter valued at $221,000. Mackenzie Financial Corp grew its holdings in Henry Schein by 97.2% in the 4th quarter. Mackenzie Financial Corp now owns 8,819 shares of the company’s stock valued at $610,000 after buying an additional 4,348 shares in the last quarter. Finally, Universal Beteiligungs und Servicegesellschaft mbH acquired a new stake in shares of Henry Schein in the 4th quarter worth $5,743,000. 96.62% of the stock is owned by hedge funds and other institutional investors.

Henry Schein Stock Down 3.1%

Henry Schein stock opened at $65.64 on Friday. The company has a market capitalization of $7.96 billion, a PE ratio of 21.17, a price-to-earnings-growth ratio of 2.23 and a beta of 0.86. The company has a debt-to-equity ratio of 0.51, a quick ratio of 0.78 and a current ratio of 1.41. Henry Schein, Inc. has a fifty-two week low of $60.56 and a fifty-two week high of $82.49. The firm has a 50 day moving average price of $68.56 and a 200 day moving average price of $69.20.

Henry Schein (NASDAQ:HSIC) last released its quarterly earnings results on Tuesday, August 5th. The company reported $1.10 EPS for the quarter, missing the consensus estimate of $1.19 by ($0.09). Henry Schein had a return on equity of 14.36% and a net margin of 3.05%.The firm had revenue of $3.24 billion for the quarter, compared to analysts’ expectations of $3.22 billion. During the same quarter in the prior year, the business earned $1.23 earnings per share. The company’s quarterly revenue was up 3.3% on a year-over-year basis. Henry Schein has set its FY 2025 guidance at 4.800-4.940 EPS. Research analysts expect that Henry Schein, Inc. will post 4.74 earnings per share for the current year.

Analysts Set New Price Targets

Several research analysts have recently weighed in on HSIC shares. Barrington Research reissued an “outperform” rating and set a $78.00 price target on shares of Henry Schein in a research report on Tuesday. Baird R W lowered shares of Henry Schein from a “strong-buy” rating to a “hold” rating in a report on Monday, July 14th. Wall Street Zen downgraded shares of Henry Schein from a “buy” rating to a “hold” rating in a report on Sunday, September 7th. Leerink Partners set a $75.00 price target on shares of Henry Schein in a research report on Monday, July 14th. Finally, Stifel Nicolaus reiterated a “hold” rating and set a $75.00 price target (down from $80.00) on shares of Henry Schein in a report on Friday, July 25th. Five equities research analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the company. According to data from MarketBeat, the company currently has an average rating of “Hold” and a consensus target price of $76.67.

Henry Schein Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.